Amarin Corp Plcuk (AMRN) Share-based Compensation (QoQ) (2010 - 2026)

Amarin Corp Plcuk (AMRN) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 44.33%
Dec 31, 2025 -17.43%
Sep 30, 2025 -67.61%
Jun 30, 2025 39.57%
Mar 31, 2025 27.19%
Dec 31, 2024 -27.59%
Sep 30, 2024 7.09%
Jun 30, 2024 -15.93%
Mar 31, 2024 12.29%
Dec 31, 2023 28.80%
Sep 30, 2023 96.62%
Jun 30, 2023 -66.97%
Mar 31, 2023 -15.97%
Dec 31, 2022 35.58%
Sep 30, 2022 -43.59%
Jun 30, 2022 42.25%
Mar 31, 2022 -39.83%
Dec 31, 2021 -3.16%
Sep 30, 2021 320.81%
Jun 30, 2021 -82.20%